Click for best price

Adoptive Cell Therapy Market Size, Share 2022

Market Analysis and Insights: Global Adoptive Cell Therapy Market

The global Adoptive Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adoptive Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adoptive Cell Therapy market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adoptive Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adoptive Cell Therapy market.

Global Adoptive Cell Therapy Scope and Market Size

Adoptive Cell Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Adoptive Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

CAR-T

TCR-T

TIL

Segment by Application

Lymphoma

Leukemia

By Company

Novartis

Juno

Kite

Adaptimmune

Fibrocell

Lineage Cell Therapeutics

BioTime

Vericel Corporation

Regeneus

Anhui Anke Biotechnology

Cellectis

NantKwest

SorrentoTherapeutics

Bellicum

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Adoptive Cell Therapy product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Adoptive Cell Therapy, with price, sales, revenue, and global market share of Adoptive Cell Therapy from 2019 to 2022.

Chapter 3, the Adoptive Cell Therapy competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Adoptive Cell Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Adoptive Cell Therapy market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Adoptive Cell Therapy.

Chapter 13, 14, and 15, to describe Adoptive Cell Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 Adoptive Cell Therapy Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global Adoptive Cell Therapy Market Insights, Forecast to 2028
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	108 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 CAR-T
1.2.3 TCR-T
1.2.4 NK
1.2.5 TIL
1.3 Market by Application
1.3.1 Global Adoptive Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lymphoma
1.3.3 Leukemia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Therapy Market Perspective (2017-2028)
2.2 Adoptive Cell Therapy Growth Trends by Region
2.2.1 Adoptive Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Adoptive Cell Therapy Historic Market Size by Region (2017-2022)
2.2.3 Adoptive Cell Therapy Forecasted Market Size by Region (2023-2028)
2.3 Adoptive Cell Therapy Market Dynamics
2.3.1 Adoptive Cell Therapy Industry Trends
2.3.2 Adoptive Cell Therapy Market Drivers
2.3.3 Adoptive Cell Therapy Market Challenges
2.3.4 Adoptive Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Therapy Players by Revenue (2017-2022)
3.1.2 Global Adoptive Cell Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cell Therapy Revenue
3.4 Global Adoptive Cell Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Therapy Revenue in 2021
3.5 Adoptive Cell Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Therapy Historic Market Size by Type (2017-2022)
4.2 Global Adoptive Cell Therapy Forecasted Market Size by Type (2023-2028)
5 Adoptive Cell Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global Adoptive Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Adoptive Cell Therapy Market Size (2017-2028)
6.2 North America Adoptive Cell Therapy Market Size by Type
6.2.1 North America Adoptive Cell Therapy Market Size by Type (2017-2022)
6.2.2 North America Adoptive Cell Therapy Market Size by Type (2023-2028)
6.2.3 North America Adoptive Cell Therapy Market Share by Type (2017-2028)
6.3 North America Adoptive Cell Therapy Market Size by Application
6.3.1 North America Adoptive Cell Therapy Market Size by Application (2017-2022)
6.3.2 North America Adoptive Cell Therapy Market Size by Application (2023-2028)
6.3.3 North America Adoptive Cell Therapy Market Share by Application (2017-2028)
6.4 North America Adoptive Cell Therapy Market Size by Country
6.4.1 North America Adoptive Cell Therapy Market Size by Country (2017-2022)
6.4.2 North America Adoptive Cell Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Adoptive Cell Therapy Market Size (2017-2028)
7.2 Europe Adoptive Cell Therapy Market Size by Type
7.2.1 Europe Adoptive Cell Therapy Market Size by Type (2017-2022)
7.2.2 Europe Adoptive Cell Therapy Market Size by Type (2023-2028)
7.2.3 Europe Adoptive Cell Therapy Market Share by Type (2017-2028)
7.3 Europe Adoptive Cell Therapy Market Size by Application
7.3.1 Europe Adoptive Cell Therapy Market Size by Application (2017-2022)
7.3.2 Europe Adoptive Cell Therapy Market Size by Application (2023-2028)
7.3.3 Europe Adoptive Cell Therapy Market Share by Application (2017-2028)
7.4 Europe Adoptive Cell Therapy Market Size by Country
7.4.1 Europe Adoptive Cell Therapy Market Size by Country (2017-2022)
7.4.2 Europe Adoptive Cell Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Therapy Market Size (2017-2028)
8.2 Asia-Pacific Adoptive Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Adoptive Cell Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Adoptive Cell Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Adoptive Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Adoptive Cell Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Adoptive Cell Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Adoptive Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Adoptive Cell Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Adoptive Cell Therapy Market Size (2017-2028)
9.2 Latin America Adoptive Cell Therapy Market Size by Type
9.2.1 Latin America Adoptive Cell Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Adoptive Cell Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Adoptive Cell Therapy Market Share by Type (2017-2028)
9.3 Latin America Adoptive Cell Therapy Market Size by Application
9.3.1 Latin America Adoptive Cell Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Adoptive Cell Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Adoptive Cell Therapy Market Share by Application (2017-2028)
9.4 Latin America Adoptive Cell Therapy Market Size by Country
9.4.1 Latin America Adoptive Cell Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Adoptive Cell Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Therapy Market Size (2017-2028)
10.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Adoptive Cell Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Adoptive Cell Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Adoptive Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Adoptive Cell Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Adoptive Cell Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Adoptive Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Adoptive Cell Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Adoptive Cell Therapy Introduction
11.1.4 Novartis Revenue in Adoptive Cell Therapy Business (2017-2022)
11.1.5 Novartis Recent Developments
11.2 Juno
11.2.1 Juno Company Details
11.2.2 Juno Business Overview
11.2.3 Juno Adoptive Cell Therapy Introduction
11.2.4 Juno Revenue in Adoptive Cell Therapy Business (2017-2022)
11.2.5 Juno Recent Developments
11.3 Kite
11.3.1 Kite Company Details
11.3.2 Kite Business Overview
11.3.3 Kite Adoptive Cell Therapy Introduction
11.3.4 Kite Revenue in Adoptive Cell Therapy Business (2017-2022)
11.3.5 Kite Recent Developments
11.4 Adaptimmune
11.4.1 Adaptimmune Company Details
11.4.2 Adaptimmune Business Overview
11.4.3 Adaptimmune Adoptive Cell Therapy Introduction
11.4.4 Adaptimmune Revenue in Adoptive Cell Therapy Business (2017-2022)
11.4.5 Adaptimmune Recent Developments
11.5 Fibrocell
11.5.1 Fibrocell Company Details
11.5.2 Fibrocell Business Overview
11.5.3 Fibrocell Adoptive Cell Therapy Introduction
11.5.4 Fibrocell Revenue in Adoptive Cell Therapy Business (2017-2022)
11.5.5 Fibrocell Recent Developments
11.6 Lineage Cell Therapeutics
11.6.1 Lineage Cell Therapeutics Company Details
11.6.2 Lineage Cell Therapeutics Business Overview
11.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Introduction
11.6.4 Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2017-2022)
11.6.5 Lineage Cell Therapeutics Recent Developments
11.7 BioTime
11.7.1 BioTime Company Details
11.7.2 BioTime Business Overview
11.7.3 BioTime Adoptive Cell Therapy Introduction
11.7.4 BioTime Revenue in Adoptive Cell Therapy Business (2017-2022)
11.7.5 BioTime Recent Developments
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Details
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Adoptive Cell Therapy Introduction
11.8.4 Vericel Corporation Revenue in Adoptive Cell Therapy Business (2017-2022)
11.8.5 Vericel Corporation Recent Developments
11.9 Regeneus
11.9.1 Regeneus Company Details
11.9.2 Regeneus Business Overview
11.9.3 Regeneus Adoptive Cell Therapy Introduction
11.9.4 Regeneus Revenue in Adoptive Cell Therapy Business (2017-2022)
11.9.5 Regeneus Recent Developments
11.10 Anhui Anke Biotechnology
11.10.1 Anhui Anke Biotechnology Company Details
11.10.2 Anhui Anke Biotechnology Business Overview
11.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Introduction
11.10.4 Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2017-2022)
11.10.5 Anhui Anke Biotechnology Recent Developments
11.11 Cellectis
11.11.1 Cellectis Company Details
11.11.2 Cellectis Business Overview
11.11.3 Cellectis Adoptive Cell Therapy Introduction
11.11.4 Cellectis Revenue in Adoptive Cell Therapy Business (2017-2022)
11.11.5 Cellectis Recent Developments
11.12 NantKwest
11.12.1 NantKwest Company Details
11.12.2 NantKwest Business Overview
11.12.3 NantKwest Adoptive Cell Therapy Introduction
11.12.4 NantKwest Revenue in Adoptive Cell Therapy Business (2017-2022)
11.12.5 NantKwest Recent Developments
11.13 SorrentoTherapeutics
11.13.1 SorrentoTherapeutics Company Details
11.13.2 SorrentoTherapeutics Business Overview
11.13.3 SorrentoTherapeutics Adoptive Cell Therapy Introduction
11.13.4 SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2017-2022)
11.13.5 SorrentoTherapeutics Recent Developments
11.14 Bellicum
11.14.1 Bellicum Company Details
11.14.2 Bellicum Business Overview
11.14.3 Bellicum Adoptive Cell Therapy Introduction
11.14.4 Bellicum Revenue in Adoptive Cell Therapy Business (2017-2022)
11.14.5 Bellicum Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Adoptive Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of CAR-T
Table 3. Key Players of TCR-T
Table 4. Key Players of NK
Table 5. Key Players of TIL
Table 6. Global Adoptive Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Adoptive Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Adoptive Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Adoptive Cell Therapy Market Share by Region (2017-2022)
Table 10. Global Adoptive Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Adoptive Cell Therapy Market Share by Region (2023-2028)
Table 12. Adoptive Cell Therapy Market Trends
Table 13. Adoptive Cell Therapy Market Drivers
Table 14. Adoptive Cell Therapy Market Challenges
Table 15. Adoptive Cell Therapy Market Restraints
Table 16. Global Adoptive Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Adoptive Cell Therapy Revenue Share by Players (2017-2022)
Table 18. Global Top Adoptive Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2021)
Table 19. Ranking of Global Top Adoptive Cell Therapy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Adoptive Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Adoptive Cell Therapy Product Solution and Service
Table 23. Date of Enter into Adoptive Cell Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Adoptive Cell Therapy Revenue Market Share by Type (2017-2022)
Table 27. Global Adoptive Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Adoptive Cell Therapy Revenue Market Share by Type (2023-2028)
Table 29. Global Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Adoptive Cell Therapy Revenue Share by Application (2017-2022)
Table 31. Global Adoptive Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Adoptive Cell Therapy Revenue Share by Application (2023-2028)
Table 33. North America Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Adoptive Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Adoptive Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Adoptive Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Adoptive Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Adoptive Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Adoptive Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Adoptive Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Adoptive Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Adoptive Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Adoptive Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Adoptive Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Adoptive Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Adoptive Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Adoptive Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Adoptive Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Adoptive Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Adoptive Cell Therapy Product
Table 66. Novartis Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 67. Novartis Recent Developments
Table 68. Juno Company Details
Table 69. Juno Business Overview
Table 70. Juno Adoptive Cell Therapy Product
Table 71. Juno Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 72. Juno Recent Developments
Table 73. Kite Company Details
Table 74. Kite Business Overview
Table 75. Kite Adoptive Cell Therapy Product
Table 76. Kite Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 77. Kite Recent Developments
Table 78. Adaptimmune Company Details
Table 79. Adaptimmune Business Overview
Table 80. Adaptimmune Adoptive Cell Therapy Product
Table 81. Adaptimmune Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 82. Adaptimmune Recent Developments
Table 83. Fibrocell Company Details
Table 84. Fibrocell Business Overview
Table 85. Fibrocell Adoptive Cell Therapy Product
Table 86. Fibrocell Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 87. Fibrocell Recent Developments
Table 88. Lineage Cell Therapeutics Company Details
Table 89. Lineage Cell Therapeutics Business Overview
Table 90. Lineage Cell Therapeutics Adoptive Cell Therapy Product
Table 91. Lineage Cell Therapeutics Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 92. Lineage Cell Therapeutics Recent Developments
Table 93. BioTime Company Details
Table 94. BioTime Business Overview
Table 95. BioTime Adoptive Cell Therapy Product
Table 96. BioTime Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 97. BioTime Recent Developments
Table 98. Vericel Corporation Company Details
Table 99. Vericel Corporation Business Overview
Table 100. Vericel Corporation Adoptive Cell Therapy Product
Table 101. Vericel Corporation Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 102. Vericel Corporation Recent Developments
Table 103. Regeneus Company Details
Table 104. Regeneus Business Overview
Table 105. Regeneus Adoptive Cell Therapy Product
Table 106. Regeneus Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 107. Regeneus Recent Developments
Table 108. Anhui Anke Biotechnology Company Details
Table 109. Anhui Anke Biotechnology Business Overview
Table 110. Anhui Anke Biotechnology Adoptive Cell Therapy Product
Table 111. Anhui Anke Biotechnology Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 112. Anhui Anke Biotechnology Recent Developments
Table 113. Cellectis Company Details
Table 114. Cellectis Business Overview
Table 115. Cellectis Adoptive Cell Therapy Product
Table 116. Cellectis Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 117. Cellectis Recent Developments
Table 118. NantKwest Company Details
Table 119. NantKwest Business Overview
Table 120. NantKwest Adoptive Cell Therapy Product
Table 121. NantKwest Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 122. NantKwest Recent Developments
Table 123. SorrentoTherapeutics Company Details
Table 124. SorrentoTherapeutics Business Overview
Table 125. SorrentoTherapeutics Adoptive Cell Therapy Product
Table 126. SorrentoTherapeutics Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 127. SorrentoTherapeutics Recent Developments
Table 128. Bellicum Company Details
Table 129. Bellicum Business Overview
Table 130. Bellicum Adoptive Cell Therapy Product
Table 131. Bellicum Revenue in Adoptive Cell Therapy Business (2017-2022) & (US$ Million)
Table 132. Bellicum Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cell Therapy Market Share by Type: 2021 VS 2028
Figure 2. CAR-T Features
Figure 3. TCR-T Features
Figure 4. NK Features
Figure 5. TIL Features
Figure 6. Global Adoptive Cell Therapy Market Share by Application: 2021 VS 2028
Figure 7. Lymphoma Case Studies
Figure 8. Leukemia Case Studies
Figure 9. Adoptive Cell Therapy Report Years Considered
Figure 10. Global Adoptive Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Adoptive Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Adoptive Cell Therapy Market Share by Region: 2021 VS 2028
Figure 13. Global Adoptive Cell Therapy Market Share by Players in 2021
Figure 14. Global Top Adoptive Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Adoptive Cell Therapy Revenue in 2021
Figure 16. North America Adoptive Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Adoptive Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 18. North America Adoptive Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 19. North America Adoptive Cell Therapy Market Size Share by Country (2017-2028)
Figure 20. United States Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Adoptive Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Adoptive Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 24. Europe Adoptive Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 25. Europe Adoptive Cell Therapy Market Size Share by Country (2017-2028)
Figure 26. Germany Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Adoptive Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Adoptive Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Adoptive Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Adoptive Cell Therapy Market Size Share by Region (2017-2028)
Figure 36. China Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Adoptive Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Adoptive Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Adoptive Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Adoptive Cell Therapy Market Size Share by Country (2017-2028)
Figure 46. Mexico Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Adoptive Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Adoptive Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Adoptive Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Adoptive Cell Therapy Market Size Share by Country (2017-2028)
Figure 52. Turkey Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Adoptive Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Novartis Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 56. Juno Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 57. Kite Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 58. Adaptimmune Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 59. Fibrocell Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 60. Lineage Cell Therapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 61. BioTime Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 62. Vericel Corporation Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 63. Regeneus Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 64. Anhui Anke Biotechnology Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 65. Cellectis Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 66. NantKwest Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 67. SorrentoTherapeutics Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 68. Bellicum Revenue Growth Rate in Adoptive Cell Therapy Business (2017-2022)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $4667

Multi User Price : $7000

Enterprise Price : $9333

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global Adoptive Cell Therapy Market Insights, Forecast to 2028